IBRN · iShares Neuroscience and Healthcare ETF ETF
iShares Trust
$39.06
-0.80%
At close · Sep 4
Net assets $5,174,384
Holdings58
1 month
+0.52%
Year to date
+20.86%
52-week range
$25.42–$43.01
30-session avg volume
3,146
Market performance
Adjusted close · up to five years
Fund profile
- Structure
- Exchange-traded product
- SEC series
- S000076483
- Report date
- Apr 30, 2026
- Holdings coverage
- Tracked U.S. equities
Portfolio concentration
Top 10 holdings—
Calculated only when the SEC filing is stored with complete portfolio coverage.
Portfolio holdings
Latest linked SEC Form NPORT-P report.
| Holding | Ticker / CUSIP | Value | Weight |
|---|---|---|---|
| Xenon Pharmaceuticals Inc | XENE | $247,641 | 4.79% |
| AXSOME THERAPEUTICS, INC. | AXSM | $237,666 | 4.59% |
| ARROWHEAD PHARMACEUTICALS, INC. | ARWR | $228,008 | 4.41% |
| ALKERMES PUBLIC LIMITED COMPANY | ALKS | $217,295 | 4.20% |
| CENTESSA PHARMACEUTICALS PLC | CNTA | $204,432 | 3.95% |
| argenx SE | ARGX | $200,902 | 3.88% |
| PTC THERAPEUTICS, INC. | PTCT | $191,146 | 3.69% |
| NEUROCRINE BIOSCIENCES, INC. | NBIX | $190,658 | 3.68% |
| BIOGEN INC. | BIIB | $190,037 | 3.67% |
| Scholar Rock Holding Corp | SRRK | $189,936 | 3.67% |
| Praxis Precision Medicines Inc | PRAX | $189,385 | 3.66% |
| ACADIA PHARMACEUTICALS INC. | ACAD | $186,964 | 3.61% |
| Dianthus Therapeutics Inc | DNTH | $175,424 | 3.39% |
| CATALYST PHARMACEUTICALS, INC. | 14888U101 | $170,130 | 3.29% |
| Denali Therapeutics Inc | DNLI | $146,016 | 2.82% |
| SUPERNUS PHARMACEUTICALS, INC. | SUPN | $144,000 | 2.78% |
| Edgewise Therapeutics Inc | EWTX | $131,023 | 2.53% |
| Dyne Therapeutics, Inc | DYN | $122,253 | 2.36% |
| AxoGen, Inc. | AXGN | $120,960 | 2.34% |
| SAREPTA THERAPEUTICS, INC. | SRPT | $114,422 | 2.21% |
| Capricor Therapeutics Inc | CAPR | $90,431 | 1.75% |
| Taysha Gene Therapies Inc | TSHA | $79,038 | 1.53% |
| Biohaven Ltd | BHVN | $67,283 | 1.30% |
| Rapport Therapeutics Inc | RAPP | $53,339 | 1.03% |
| Bright Minds Biosciences Inc | DRUG | $47,405 | 0.92% |
| Annexon Inc | ANNX | $41,372 | 0.80% |
| Alto Neuroscience Inc | ANRO | $40,312 | 0.78% |
| INTEGRA LIFESCIENCES HOLDINGS CORPORATION | IART | $38,735 | 0.75% |
| LB Pharmaceuticals Inc | LBRX | $32,852 | 0.63% |
| Brainsway Ltd | BWAY | $30,951 | 0.60% |
| Ceribell Inc | CBLL | $26,954 | 0.52% |
| Prothena Corporation PLC | PRTA | $26,456 | 0.51% |
| Relmada Therapeutics Inc | RLMD | $25,072 | 0.48% |
| Solid Biosciences Inc | SLDB | $23,973 | 0.46% |
| Design Therapeutics Inc | DSGN | $23,718 | 0.46% |
| Neuropace Inc | NPCE | $23,570 | 0.46% |
| Regenxbio Inc | RGNX | $22,712 | 0.44% |
| Benitec Biopharma Inc | BNTC | $21,666 | 0.42% |
| MapLight Therapeutics Inc | MPLT | $21,576 | 0.42% |
| VANDA PHARMACEUTICALS INC. | VNDA | $21,272 | 0.41% |
| NEUROGENE INC. | NGNE | $17,689 | 0.34% |
| OVID THERAPEUTICS INC. | OVID | $17,628 | 0.34% |
| Anavex Life Sciences Corp | AVXL | $16,510 | 0.32% |
| Entrada Therapeutics Inc | TRDA | $15,903 | 0.31% |
| Clearpoint Neuro Inc | CLPT | $15,853 | 0.31% |
| AC Immune SA | ACIU | $10,151 | 0.20% |
| Alector Inc | ALEC | $9,736 | 0.19% |
| Inhibikase Therapeutics Inc | IKT | $9,601 | 0.19% |
| Voyager Therapeutics Inc | VYGR | $9,377 | 0.18% |
| Larimar Therapeutics Inc | LRMR | $9,261 | 0.18% |